Skip to main content
Smart Investors Daily
Coloplast A/S logo

OTC · CLPBY

Coloplast A/S

Healthcare · Medical - Instruments & Supplies

$6.75

Up+$0.01 (+0.15%)

Updated Sep 11, 2026, 5:51 AM

SID Score

5.5/10

Composite research score

Smart Money

46/100

Neutral

Market cap
19.84B
P/E ratio
31.03
Dividend yield
5.24%
52-week range
— – —
Volume
27.14K
Avg. volume
405.67K

Price performance

CLPBY price history

1M range · 0 trading sessions · Daily adjusted prices

CLPBY does not have enough price history for the selected period.

Data unavailable

Market data is busy. Please try again shortly.

Latest CLPBY news

The latest Smart Investors Daily articles mentioning CLPBY.

CLPBY research

Overview

Company profile and research snapshot.

Company profile

COLOPLAST AS SP/ADR

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Average target
$14.45
Implied upside
Analysts
CLPBY recent ratings
DateFirmRatingTarget
Jul 13, 2026JYSKE BANKBuy
Jul 13, 2026BERENBERGHold
Jul 8, 2026ROTHSCHILD & CO REDBURNNeutral
Jul 1, 2026JEFFERIESBuy
Jun 11, 2026EQUITA SIMHold
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 4, 2026

Supporting the continued long-term and stable ownership of Coloplast

Coloplast has been informed that the Danish Financial Supervisory Authority (FSA) has today announced that it has notified Niels Peter Louis-Hansen that it has granted an exemption from the obligation to make a mandatory takeover offer to the shareholders of Coloplast A/S in connection with the contemplated transfer of a controlling indirect ownership interest in Coloplast A/S from NPLH Holding ApS to a non-profit foundation. Reference is made to the Danish Financial Supervisory Authority’s prio

Benzinga · Aug 18, 2026

Full Transcript: Coloplast Q3 2026 Earnings Call

Coloplast (OTC:CLPBY) released third-quarter financial results and hosted an earnings call on Tuesday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings call transcripts and

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.